Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice
Aim. This observational (non-interventional) study was aimed at obtaining data on practitioners’ commitment to prescribing rifaximin-α therapy to patients with uncomplicated diverticular disease (UDD), to assess patients’ adherence to such prescriptions, as well as to assess physicians’ and patients...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2020-04-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/438 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860152484233216 |
|---|---|
| author | O. S. Shifrin E. A. Poluektova A. V. Korolev T. I. Semenova M. V. Shein G. N. Leksikova O. A. Tokareva O. E. Davydova P. S. Andreev S. E. Katorkin A. A. Chernov A. V. Zhuravlev O. S. Sek A. A. Kopina N. Yu. Samokhina Yu. V. Gorozhankina M. F. Samigullin V. S. Groshilin E. N. Borisova T. A. Petrova I. Yu. Pirogova S. V. Mednikov N. V. Smagin A. S. Sarsenbaeva N. V. Smirnova L. G. Kirsanova N. M. Malyutina M. A. Smirnova E. N. Shleikova V. T. Ivashkin |
| author_facet | O. S. Shifrin E. A. Poluektova A. V. Korolev T. I. Semenova M. V. Shein G. N. Leksikova O. A. Tokareva O. E. Davydova P. S. Andreev S. E. Katorkin A. A. Chernov A. V. Zhuravlev O. S. Sek A. A. Kopina N. Yu. Samokhina Yu. V. Gorozhankina M. F. Samigullin V. S. Groshilin E. N. Borisova T. A. Petrova I. Yu. Pirogova S. V. Mednikov N. V. Smagin A. S. Sarsenbaeva N. V. Smirnova L. G. Kirsanova N. M. Malyutina M. A. Smirnova E. N. Shleikova V. T. Ivashkin |
| author_sort | O. S. Shifrin |
| collection | DOAJ |
| description | Aim. This observational (non-interventional) study was aimed at obtaining data on practitioners’ commitment to prescribing rifaximin-α therapy to patients with uncomplicated diverticular disease (UDD), to assess patients’ adherence to such prescriptions, as well as to assess physicians’ and patients’ satisfaction with this drug under the conditions of outpatient practice.Materials and methods. 27 research physicians in 22 research centres located in 15 Russian cities and 250 patients participated in an open, prospective multicentre observational study. The observation lasted for 6 months with an interim assessment after 3 months. Physicians’ prescription of rifaximin-α (dose, duration of administration, number of prescribed courses) was evaluated, as well as patients’ compliance expressed as the ratio of the actual number of taken pills to the number of prescribed pills during each course according to the MMAS-4 scale. Such symptoms, as abdominal pain, constipation, diarrhea, flatulence and tenesmus were evaluated using a 4-score scale. At the end of the study, physicians’ and patients’ satisfaction with the treatment was evaluated using a 5-score scale.Results. One fifth — 52 patients (20.8%)—had received rifaximin-α therapy prior to inclusion in the study. Most frequently, rifaximin-α therapy was prescribed monthly at a dose of 400 mg 2 times a day for 7 days. 67.6% of patients received 6 courses of treatment during the study period. The proportion of patients who received more than one course of treatment over 6 months was 97.6%. During almost all treatment courses (97.5%), patients’ compliance was more than 80%. The total score of symptom intensity decreased from 5.6 at the inclusion visit, to 2.2 points at the second visit and to 0.9 points at the end of the observation. A statistically significant (p <0.05) positive dynamics was observed in relation to all evaluated symptoms (abdominal pain, constipation, diarrhea, flatulence, tenesmus). By the end of the study, 59.6% of patients and 68.8% of physicians rated the treatment results as “excellent”, 25.2% of patients and 20.4% of doctors as “good”.Conclusions. During the observation, a significant decrease in the severity of UDD symptoms, such as abdominal pain, constipation, diarrhea, flatulence and tenesmus was noted. No adverse effects associated with rifaximin-α were reported. The data obtained confirm the previously published results of randomized controlled trials on the efficacy and safety of rifaximin-α in UDD. |
| format | Article |
| id | doaj-art-a82a2c6578e4481eb40f06b39d33f350 |
| institution | Kabale University |
| issn | 1382-4376 2658-6673 |
| language | Russian |
| publishDate | 2020-04-01 |
| publisher | Gastro LLC |
| record_format | Article |
| series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| spelling | doaj-art-a82a2c6578e4481eb40f06b39d33f3502025-02-10T16:14:36ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732020-04-01301142510.22416/1382-4376-2020-30-1-14-25350Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient PracticeO. S. Shifrin0E. A. Poluektova1A. V. Korolev2T. I. Semenova3M. V. Shein4G. N. Leksikova5O. A. Tokareva6O. E. Davydova7P. S. Andreev8S. E. Katorkin9A. A. Chernov10A. V. Zhuravlev11O. S. Sek12A. A. Kopina13N. Yu. Samokhina14Yu. V. Gorozhankina15M. F. Samigullin16V. S. Groshilin17E. N. Borisova18T. A. Petrova19I. Yu. Pirogova20S. V. Mednikov21N. V. Smagin22A. S. Sarsenbaeva23N. V. Smirnova24L. G. Kirsanova25N. M. Malyutina26M. A. Smirnova27E. N. Shleikova28V. T. Ivashkin29I. M. Sechenov First Moscow State Medical University (Sechenov University)I. M. Sechenov First Moscow State Medical University (Sechenov University)I. M. Sechenov First Moscow State Medical University (Sechenov University)Pskov City HospitalStolitsa Medical CentreChekhovskaya Central District PolyclinicNoginsk Central District Hospital, Polyclinic No. 2Samara State Medical UniversitySamara State Medical UniversitySamara State Medical UniversitySamara State Medical UniversitySamara State Medical UniversitySt. Petersburg MetropolitenKrasnoyarsk City Polyclinic No. 4Krasnoyarsk City Polyclinic No. 4SOVA Multispecialised Medical ClinicKORL LLCRostov State Medical UniversityCity hospital named after N. А. SemashkoDistrict Hospital of Kostroma District No.1LLC MC “Lotus” Center for Gastroenterology and HepatologyMedical-sanitary Unit No. 8 of the Federal Bio-Medical AgencyKinzersky’s Clinic.South Ural State Medical University, Regional Clinical Hospital No. 4Kostroma Regional Clinical Hospital named after E. I. KorolevCity Clinical Hospital named after I. V. Davydovsky of the Moscow Department of Healthcare, Clinical Diagnostic CentreMedical Centre of Diagnostics and TherapyCity Clinical Hospital No. 1Medical Centre “Venous esthetical surgery”I. M. Sechenov First Moscow State Medical University (Sechenov University)Aim. This observational (non-interventional) study was aimed at obtaining data on practitioners’ commitment to prescribing rifaximin-α therapy to patients with uncomplicated diverticular disease (UDD), to assess patients’ adherence to such prescriptions, as well as to assess physicians’ and patients’ satisfaction with this drug under the conditions of outpatient practice.Materials and methods. 27 research physicians in 22 research centres located in 15 Russian cities and 250 patients participated in an open, prospective multicentre observational study. The observation lasted for 6 months with an interim assessment after 3 months. Physicians’ prescription of rifaximin-α (dose, duration of administration, number of prescribed courses) was evaluated, as well as patients’ compliance expressed as the ratio of the actual number of taken pills to the number of prescribed pills during each course according to the MMAS-4 scale. Such symptoms, as abdominal pain, constipation, diarrhea, flatulence and tenesmus were evaluated using a 4-score scale. At the end of the study, physicians’ and patients’ satisfaction with the treatment was evaluated using a 5-score scale.Results. One fifth — 52 patients (20.8%)—had received rifaximin-α therapy prior to inclusion in the study. Most frequently, rifaximin-α therapy was prescribed monthly at a dose of 400 mg 2 times a day for 7 days. 67.6% of patients received 6 courses of treatment during the study period. The proportion of patients who received more than one course of treatment over 6 months was 97.6%. During almost all treatment courses (97.5%), patients’ compliance was more than 80%. The total score of symptom intensity decreased from 5.6 at the inclusion visit, to 2.2 points at the second visit and to 0.9 points at the end of the observation. A statistically significant (p <0.05) positive dynamics was observed in relation to all evaluated symptoms (abdominal pain, constipation, diarrhea, flatulence, tenesmus). By the end of the study, 59.6% of patients and 68.8% of physicians rated the treatment results as “excellent”, 25.2% of patients and 20.4% of doctors as “good”.Conclusions. During the observation, a significant decrease in the severity of UDD symptoms, such as abdominal pain, constipation, diarrhea, flatulence and tenesmus was noted. No adverse effects associated with rifaximin-α were reported. The data obtained confirm the previously published results of randomized controlled trials on the efficacy and safety of rifaximin-α in UDD.https://www.gastro-j.ru/jour/article/view/438diverticular diseaserifaximin-αnon-interventional study |
| spellingShingle | O. S. Shifrin E. A. Poluektova A. V. Korolev T. I. Semenova M. V. Shein G. N. Leksikova O. A. Tokareva O. E. Davydova P. S. Andreev S. E. Katorkin A. A. Chernov A. V. Zhuravlev O. S. Sek A. A. Kopina N. Yu. Samokhina Yu. V. Gorozhankina M. F. Samigullin V. S. Groshilin E. N. Borisova T. A. Petrova I. Yu. Pirogova S. V. Mednikov N. V. Smagin A. S. Sarsenbaeva N. V. Smirnova L. G. Kirsanova N. M. Malyutina M. A. Smirnova E. N. Shleikova V. T. Ivashkin Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice Российский журнал гастроэнтерологии, гепатологии, колопроктологии diverticular disease rifaximin-α non-interventional study |
| title | Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice |
| title_full | Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice |
| title_fullStr | Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice |
| title_full_unstemmed | Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice |
| title_short | Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice |
| title_sort | russian non interventional study of the efficacy and tolerability of rifaximin α therapy in patients with uncomplicated diverticular disease under the conditions of outpatient practice |
| topic | diverticular disease rifaximin-α non-interventional study |
| url | https://www.gastro-j.ru/jour/article/view/438 |
| work_keys_str_mv | AT osshifrin russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT eapoluektova russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT avkorolev russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT tisemenova russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT mvshein russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT gnleksikova russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT oatokareva russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT oedavydova russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT psandreev russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT sekatorkin russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT aachernov russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT avzhuravlev russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT ossek russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT aakopina russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT nyusamokhina russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT yuvgorozhankina russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT mfsamigullin russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT vsgroshilin russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT enborisova russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT tapetrova russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT iyupirogova russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT svmednikov russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT nvsmagin russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT assarsenbaeva russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT nvsmirnova russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT lgkirsanova russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT nmmalyutina russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT masmirnova russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT enshleikova russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice AT vtivashkin russiannoninterventionalstudyoftheefficacyandtolerabilityofrifaximinatherapyinpatientswithuncomplicateddiverticulardiseaseundertheconditionsofoutpatientpractice |